Publications


Publications1
Jimenez A, Adisa A, Woodham C, Saleh M. Determination of polycyclic aromatic hydrocarbons in roasted coffee. J Environ Sci Health B. 2014;49(11):828-35. PubMed PMID: 25190557.
Liang S, Bian X, Sivils J, Neckers LM, Cox MB, Xie H. Quantification of a New Anti- Cancer Molecule MJC13 Using a Rapid, Sensitive, and Reliable Liquid Chromatography-Tandem Mass Spectrometry Method.  Am J Mod Chromatogr. 2014;1(1):1-11. PubMed PMID: 25594071; PubMed Central PMCID: PMC4292881.
Meng QH, Xu E, Hildebrandt MA, Liang D, Lu K, Ye Y, Wagar EA, Wu X. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Clin Chem. 2014 Jan;60(1):222-32. PubMed PMID: 24146310.
Melancon MP, Zhou M, Zhang R, Xiong C, Allen P, Wen X, Huang Q, Wallace M, Myers JN, Stafford RJ, Liang D, Ellington AD, Li C. Selective uptake and imaging of aptamer- and antibody-conjugated hollow nanospheres targeted to epidermal growth factor receptors overexpressed in head and neck cancer. ACS Nano. 2014 May 27;8(5):4530-8. PubMed PMID: 24754567; PubMed Central PMCID: PMC4046795
Robinson K, Mock C, Liang D. Pre-formulation studies of resveratrol. Drug Dev Ind Pharm. 2014 Sep 16;PubMed PMID: 25224342.
Liang S, Bian X, Liang D, Sivils JC, Neckers LM, Cox MB, Xie H. Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2014 Nov 7; PubMed PMID: 25380396.
Mathew OP, Ranganna K, Milton SG. Involvement of the Antioxidant Effect and Anti- inflammatory Response in Butyrate-Inhibited Vascular Smooth Muscle Cell Proliferation. Pharmaceuticals (Basel). 2014 Nov 10;7(11):1008-27. PubMed PMID: 25390157; PubMed Central PMCID: PMC4246201.
You J, Zhao J, Wen X, Wu C, Huang Q, Guan F, Wu R, Liang D, Li C. Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles. J Control Release. 2015 Mar 28;202:40-8. PubMed PMID: 25637565.
Liang S, Sanchez-Espiridion B, Xie H, Ma J, Wu X, Liang D. Determination of proline in human serum by a robust LC-MS/MS method: application to identification of human metabolites as candidate biomarkers for esophageal cancer early detection and risk stratification. Biomed Chromatogr. 2015 Apr;29(4):570-7. PubMed PMID: 25164985; PubMed Central PMCID: PMC4344925.
Adisa A, Jimenez A, Woodham C, Anthony K, Nguyen T, Saleh MA. Determination of polycyclic aromatic hydrocarbons in dry tea. J Environ Sci Health B. 2015;50(8):552-9. PubMed PMID: 26065515; NIHMSID: 773858.
Complete Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X,  Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, Lippman SM, Wu X. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res. 2015 Jan 1;21(1):193-200. PubMed PMID: 25336700; PubMed Central PMCID: PMC4286447.
Wang Y, Ye Y, Lin J, Meyer L, Wu X, Lu K, Liang D. Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome. Mol Carcinog. 2015 Jun;54(6):430-9. PubMed PMID: 25867973; NIHMSID: 773564.
Zhou M, Li J, Liang S, Sood AK, Liang D, Li C. CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal  Therapy. ACS Nano. 2015 Jul 28;9(7):7085-96. PubMed PMID: 26098195.
Sanchez-Espiridion B, Liang D, Ajani JA, Liang S, Ye Y, Hildebrandt MA, Gu J, Wu X.
Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted  Metabolic Profiling. Clin Gastroenterol Hepatol. 2015 Oct;13(10):1730-1737.e9. PubMed PMID: 25998788; PubMed Central PMCID: PMC4596233.
Nguyen T, Aparicio M, Saleh MA. Accurate Mass GC/LC-Quadrupole Time of Flight Mass Spectrometry Analysis of Fatty Acids and Triacylglycerols of Spicy Fruits from the Apiaceae Family. Molecules. 2015 Dec 2;20(12):21421-32. PubMed PMID: 26633337; NIHMSID: 773863.
Liang S, Bian X, Liang D, Sivils JC, Neckers LM, Cox MB, Xie H. Solution formulation  development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2016 Feb;21(1):121-6. PubMed PMID: 25380396; PubMed Central PMCID: PMC4428990.
Selvam C, Thilagavathi R, Narasimhan B, Kumar P, Jordan BC, Ranganna K. Computer-aided design of negative allosteric modulators of metabotropic glutamate receptor 5 (mGluR5): Comparative molecular field analysis of aryl ether derivatives. Bioorg Med Chem Lett. 2016 Feb 15;26(4):1140-4. PubMed PMID: 26826734; NIHMSID: 755537.
Jordan BC, Mock CD, Thilagavathi R, Selvam C. Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment. Life Sci. 2016 Mar 23;PubMed PMID: 27018446; NIHMSID: 773621.

U.S. Patents

U.S. Patents
Xie, H. Liang, S.; Cox, M.B.; Neckers, L.; “FKBP52 Targeting Agent Pharmaceutical Compositions”  U.S. Patent Application No. 61/788,716), 2014 Liang D, Joseph MK, John J, Abobo CV. “Etravirine Formulations and Uses Thereof”.  US Patent No. 8,703,786 B2, published April 22, 2014
Dong, Cai, Xian C. Li, Zhifeng Ren, Renard L. Thomas, Volatile Organic Gases as Bioindicators for Transplant Rejection, US 2015/0031582 A1, January 29, 2015. Olaleye OA, John SF, Isichei AC, Liu JO, Maldonado R, and Endsley J. Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases US 2015/ 0141415 A1, May 21, 2015.
Chow DS, Gupta P, Qi Y, Liang D. “Parenteral and Oral Formulations of Benzimidazoles”. US Patent No. 9,259,390 B2, and 9,259,391 B2, both published Feb. 16, 2016 Xie, H.; Cox, M.B; Ekpenyong, O. “Intravenous Formulation and LC/MS/MS Analysis Method for GMC1” (U.S. Provisional ApplicationNo. 62/314,579), Mar. 29, 2016